Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities (QoQ) (2010 - 2025)
Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Ironwood Pharmaceuticals | 676.53 Mn | 597.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 150.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 93.55% |
| Sep 30, 2024 | 72.41% |
| Jun 30, 2024 | 14.71% |
| Mar 31, 2024 | 98.38% |
| Dec 31, 2023 | 81.49% |
| Sep 30, 2023 | 97.74% |
| Jun 30, 2023 | -7,688,300.00% |
| Mar 31, 2023 | -148.15% |
| Dec 31, 2022 | 140.91% |
| Sep 30, 2022 | 25.00% |
| Jun 30, 2022 | -877.78% |
| Mar 31, 2022 | 92.97% |
| Jun 30, 2020 | 73.85% |
| Mar 31, 2020 | 45.96% |
| Dec 31, 2019 | 63.55% |
| Sep 30, 2019 | -200.54% |
| Jun 30, 2019 | -294.94% |
| Mar 31, 2019 | -92.88% |